Obstructive Jaundice - Initial Workup

Key Points

• First distinguish uncomplicated obstruction from acute cholangitis, which requires urgent antibiotics and drainage.
• Right-upper-quadrant ultrasound is the usual first imaging test.
• MRCP and EUS define biliary anatomy without the procedural risks of diagnostic ERCP.
• ERCP is primarily therapeutic for drainage, stone extraction, stenting, and selected tissue sampling.
• CA 19-9 can be falsely elevated by cholestasis and should not diagnose malignancy by itself.
• Malignant hilar obstruction requires coordinated endoscopic, radiologic, surgical, and oncologic planning.

Algorithm

1. Confirm a cholestatic laboratory pattern and assess for fever, hypotension, altered mental status, and abdominal pain.
2. Obtain ultrasound to look for duct dilation and gallstones.
3. If cholangitis is present, start antibiotics and arrange urgent drainage.
4. If stable without infection, use MRCP, EUS, or pancreas-protocol CT according to suspected level and cause.
5. Use ERCP when therapeutic intervention or targeted sampling is expected.
6. Refer malignant or complex strictures for multidisciplinary planning.
7. Trend bilirubin, alkaline phosphatase, renal function, and clinical symptoms after drainage or definitive therapy.

Clinical Synopsis & Reasoning

Obstructive jaundice typically produces dark urine, pale stools, pruritus, and a cholestatic laboratory pattern with alkaline phosphatase and gamma-glutamyl transferase elevation out of proportion to aminotransferases. Common causes include choledocholithiasis, pancreatic or biliary malignancy, benign postoperative or inflammatory strictures, chronic pancreatitis, and less common parasitic or congenital disease. The immediate question is whether infection is present. Fever, right-upper-quadrant pain, jaundice, hypotension, or altered mental status suggest acute cholangitis and convert a diagnostic workup into an urgent drainage problem.

Ultrasound is the usual first imaging test because it rapidly identifies gallstones, gallbladder disease, and intrahepatic or extrahepatic ductal dilation. Absence of dilation does not completely exclude early obstruction. CT provides broader assessment for pancreatic mass, complications, and alternative diagnoses. MRCP is noninvasive and maps the biliary tree well, while EUS is highly sensitive for small common-duct stones and distal lesions. ERCP carries procedure risks and is best used when drainage, stone extraction, stenting, or tissue sampling is likely to be required.

The level of obstruction helps frame malignancy. A distal obstruction may arise from pancreatic head cancer, ampullary tumor, or distal cholangiocarcinoma. Hilar obstruction raises concern for perihilar cholangiocarcinoma or metastatic disease. Weight loss, painless progressive jaundice, palpable gallbladder, and markedly elevated bilirubin increase concern for malignancy but are not diagnostic. Tumor markers such as CA 19-9 are nonspecific in active cholestasis and should not be used alone to diagnose cancer.

Treatment Strategy & Disposition

If acute cholangitis is suspected, obtain blood cultures, start broad-spectrum antibiotics covering enteric gram-negative organisms and anaerobes according to severity and local resistance, and arrange urgent biliary drainage, generally by ERCP when anatomy permits. Antibiotics cannot sterilize a persistently obstructed infected biliary tree reliably without source control. Hemodynamic resuscitation and sepsis care proceed in parallel.

For uncomplicated obstruction, manage the cause rather than the bilirubin value itself. Choledocholithiasis may require ERCP for stone extraction followed by cholecystectomy when appropriate. Malignant obstruction often requires multidisciplinary planning because the sequence of tissue diagnosis, biliary stenting, surgery, and oncologic therapy depends on tumor location and resectability. Hilar lesions are particularly complex and should not be instrumented repeatedly without a drainage strategy.

Relieve severe pruritus with disease-specific therapy after the obstruction plan is established. Correct vitamin K deficiency when prolonged cholestasis has impaired absorption and an invasive procedure is planned. Avoid routine prophylactic antibiotics in uncomplicated sterile obstruction unless a procedure-specific indication exists. Refer early to gastroenterology, surgery, or oncology when malignancy, difficult anatomy, recurrent obstruction, or failed endoscopic drainage is suspected.

Epidemiology / Risk Factors

• Choledocholithiasis is a common benign cause of acute extrahepatic obstruction.
• Pancreatic adenocarcinoma and cholangiocarcinoma are major malignant causes of progressive obstructive jaundice.
• Risk of cholangitis rises when an obstructed biliary system becomes infected, particularly after instrumentation.
• Incidental biliary dilation is increasingly detected on cross-sectional imaging and requires interpretation with symptoms and laboratory findings.

Investigations

When to Involve Oncology or Surgery

Pharmacology

Prognosis / Complications

• Stone-related obstruction generally has an excellent prognosis after definitive duct clearance and gallbladder management.
• Acute cholangitis can progress to septic shock without drainage.
• Malignant obstruction prognosis depends on tumor stage, resectability, and response to therapy.
• Persistent cholestasis can cause malabsorption, coagulopathy, pruritus, and recurrent infection.

Patient Education / Counseling

• Explain that jaundice is a sign of blocked bile flow and that treatment depends on the cause and whether infection is present.
• Seek urgent care for fever, chills, worsening abdominal pain, confusion, or fainting because these can signal cholangitis.
• Discuss that ERCP is usually performed to treat the blockage rather than simply to take pictures.
• When cancer is suspected, explain why several specialists may need to plan tissue diagnosis and drainage before definitive therapy.

Notes

The major procedural principle is to avoid using ERCP as a default diagnostic test when a noninvasive study can answer the question. ERCP earns its risk when it is expected to drain, extract, stent, or sample.

Infected obstruction is different. In cholangitis, source control is urgent, and definitive biliary decompression should not be delayed by an overly long malignancy workup.

References

1. ASGE Guidelines — Link
2. ASGE Guideline on the Management of Cholangitis — Link